Comparison of Three Statistical Methods for Establishing Tentative Wild-Type Population and Epidemiological Cutoff Values for Echinocandins, Amphotericin B, Flucytosine, and Six Candida Species as Determined by the Colorimetric Sensititre YeastOne Method
Year: 2012
Type: article
Abstract: The Sensititre YeastOne (SYO) method is a widely used method to determine the susceptibility of Candida spp. to antifungal agents. CLSI clinical breakpoints (CBP) have been reported for antifungals, but not using this method. In the absence of CBP, epidemiological cutoff values (ECVs) are useful to separate wild-type (WT) isolates (those without mechanisms of resistance) from non-WT isolates (those that can harbor some resistance mechanisms), which is the goal of any susceptibility test. The ECVs for five agents, obtained using the MIC distributions determined by the SYO test, were calculated and contrasted with those for three statistical methods and the MIC(50) and modal MIC, both plus 2-fold dilutions. The median ECVs (in mg/liter) (% of isolates inhibited by MICs equal to or less than the ECV; number of isolates tested) of the five methods for anidulafungin, micafungin, caspofungin, amphotericin B, and flucytosine, respectively, were as follows: 0.25 (98.5%; 656), 0.06 (95.1%; 659), 0.25 (98.7%; 747), 2 (100%; 923), and 1 (98.5%; 915) for Candida albicans; 8 (100%; 352), 4 (99.2%; 392), 2 (99.2%; 480), 1 (99.8%; 603), and 0.5 (97.9%; 635) for C. parapsilosis; 1 (99.2%; 123), 0.12 (99.2%; 121), 0.25 (99.2%; 138), 2 (100%; 171), and 0.5 (97.2%; 175) for C. tropicalis; 0.12 (96.6%; 174), 0.06 (96%; 176), 0.25 (98.4%; 188), 2 (100%; 209), and 0.25 (97.6%; 208) for C. glabrata; 0.25 (97%; 33), 0.5 (93.9%; 33), 1 (91.9%; 37), 4 (100%; 51), and 32 (100%; 53) for C. krusei; and 4 (100%; 33), 2 (100%; 33), 2 (100%; 54), 1 (100%; 90), and 0.25 (93.4%; 91) for C. orthopsilosis. The three statistical methods gave similar ECVs (within one dilution) and included ≥ 95% of isolates. These tentative ECVs would be useful for monitoring the emergence of isolates with reduced susceptibility by use of the SYO method.
Source: Journal of Clinical Microbiology
DOI: 10.1128/jcm.01730-12
Authors: Emilia Cantón, Javier Pemán, David Hervás, Carmen Iñiguez, David Navarro, Julia Echeverría, José Martínez-Alarcón, Dionisia Fontanals, Bárbara Gomila-Sard, Buenaventura Buendía, Luis Torroba, Josefina Ayats, Angel Bratos, Ferran Sánchez-Reus, Isabel Fernández-Natal, the FUNGEMYCA Study Group
Institutions: Hospital Universitari i Politècnic La Fe, Instituto de Investigación Sanitaria La Fe, Universitat de València, Hospital Clínico Universitario de Valencia, Donostiako Unibertsitate Ospitalea, Hospital General Universitario de Ciudad Real, Corporació Sanitària Parc Taulí, Hospital Universitario de La Princesa, Hospital Virgen del Camino, Bellvitge University Hospital, Hospital Clínico Universitario de Valladolid, Hospital de Sant Pau, Complejo Asistencial Universitario de León
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2089758421
